These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 12220942

  • 1. Single-dose comparison of formoterol (Oxis) Turbuhaler 6 microg and formoterol Aerolizer 12 microg in moderate to severe asthma: a randomised, crossover study.
    Schlimmer P.
    Pulm Pharmacol Ther; 2002; 15(4):369-74. PubMed ID: 12220942
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Dose-related efficacy and safety of formoterol (Oxis) Turbuhaler compared with salmeterol Diskhaler in children with asthma.
    Pohunek P, Matulka M, Rybnícek O, Kopriva F, Honomichlová H, Svobodová T.
    Pediatr Allergy Immunol; 2004 Feb; 15(1):32-9. PubMed ID: 14998380
    [Abstract] [Full Text] [Related]

  • 4. A randomized, double-blind, double-dummy, single-dose, crossover trial evaluating the efficacy and safety profiles of two dose levels (12 and 24 microg) of formoterol-HFA (pMDI) vs. those of a dose level (24 microg) of formoterol-DPI (Foradil/Aerolizer) and of placebo (pMDI or Aerolizer) in moderate to severe asthmatic patients.
    Bousquet J, Guenolé E, Duvauchelle T, Vicaut E, Lefrançois G.
    Respiration; 2005 Feb; 72 Suppl 1():13-9. PubMed ID: 15915008
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial.
    Noonan M, Rosenwasser LJ, Martin P, O'Brien CD, O'Dowd L.
    Drugs; 2006 Feb; 66(17):2235-54. PubMed ID: 17137405
    [Abstract] [Full Text] [Related]

  • 8. Formoterol Turbuhaler 4.5 microg (delivered dose) has a rapid onset and 12-h duration of bronchodilation.
    Selroos O, Ekström T.
    Pulm Pharmacol Ther; 2002 Feb; 15(2):175-83. PubMed ID: 12090792
    [Abstract] [Full Text] [Related]

  • 9. Similar efficacy following four weeks treatment of asthmatics with formoterol 12 micrograms b.d. delivered by two different dry powder inhalers: differences in inhaler handling.
    Eliraz A, Ramirez-Rivera A, Ferranti P, Holzer R, García JM, Turcotte C, Rapatz G, Pfister P, Overend T, Kottakis J.
    Int J Clin Pract; 2001 Apr; 55(3):164-70. PubMed ID: 11351769
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Tolerability to high doses of formoterol and terbutaline via Turbuhaler for 3 days in stable asthmatic patients.
    Tötterman KJ, Huhti L, Sutinen E, Backman R, Pietinalho A, Falck M, Larsson P, Selroos O.
    Eur Respir J; 1998 Sep; 12(3):573-9. PubMed ID: 9762782
    [Abstract] [Full Text] [Related]

  • 12. Assessment of a relative therapeutic index between inhaled formoterol and salbuterol in asthma patients.
    Rosenborg J, Larsson P, Rott Z, Böcskei C, Poczi M, Juhász G.
    Eur J Clin Pharmacol; 2002 Jul; 58(4):S61-7. PubMed ID: 12214580
    [Abstract] [Full Text] [Related]

  • 13. Relative systemic dose potency and tolerability of inhaled formoterol and salbutamol in healthy subjects and asthmatics.
    Rosenborg J, Bengtsson T, Larsson P, Blomgren A, Persson G, Lötvall J.
    Eur J Clin Pharmacol; 2000 Aug; 56(5):363-70. PubMed ID: 11009043
    [Abstract] [Full Text] [Related]

  • 14. Formoterol (OXIS) Turbuhaler as a rescue therapy compared with salbutamol pMDI plus spacer in patients with acute severe asthma.
    Boonsawat W, Charoenratanakul S, Pothirat C, Sawanyawisuth K, Seearamroongruang T, Bengtsson T, Brander R, Selroos O.
    Respir Med; 2003 Sep; 97(9):1067-74. PubMed ID: 14509562
    [Abstract] [Full Text] [Related]

  • 15. A randomized, double-blind, double-dummy, single-dose, efficacy crossover trial comparing formoterol-HFA (pMDI) versus formoterol-DPI (Aerolizer) and placebo (pMDI or Aerolizer) in asthmatic patients.
    Bousquet J, Huchon G, Leclerc V, Vicaut E, Lefrançois G.
    Respiration; 2005 Sep; 72 Suppl 1():6-12. PubMed ID: 15915007
    [Abstract] [Full Text] [Related]

  • 16. Formoterol delivered via the dry powder Aerolizer inhaler versus albuterol MDI and placebo in mild-to-moderate asthma: a randomized, double-blind, double-dummy trial.
    Pleskow W, LaForce CF, Yegen U, Matos D, Della Cioppa G.
    J Asthma; 2003 Sep; 40(5):505-14. PubMed ID: 14529100
    [Abstract] [Full Text] [Related]

  • 17. Equivalent bronchodilation with budesonide/formoterol combination via Easyhaler and Turbuhaler in patients with asthma.
    Lähelmä S, Vahteristo M, Metev H, Taseva M, Stamatova N, Bartha A, Schlezák J, Sairanen U.
    Respir Med; 2016 Nov; 120():31-35. PubMed ID: 27817813
    [Abstract] [Full Text] [Related]

  • 18. Formoterol delivered via a new multi-dose dry powder inhaler (Certihaler) is as effective and well tolerated as the formoterol dry powder inhaler (Aerolizer) in children with persistent asthma.
    Chuchalin AG, Manjra AI, Rozinova NN, Skopková O, Cioppa GD, Till D, Kaiser G, Fashola T, Kottakis J.
    J Aerosol Med; 2005 Nov; 18(1):63-73. PubMed ID: 15741775
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics and tolerability of formoterol in healthy volunteers after a single high dose of Foradil dry powder inhalation via Aerolizer.
    Lecaillon JB, Kaiser G, Palmisano M, Morgan J, Della Cioppa G.
    Eur J Clin Pharmacol; 1999 Apr; 55(2):131-8. PubMed ID: 10335908
    [Abstract] [Full Text] [Related]

  • 20. Oxis (formoterol given by Turbuhaler) showed as rapid an onset of action as salbutamol given by a pMDI.
    Seberová E, Andersson A.
    Respir Med; 2000 Jun; 94(6):607-11. PubMed ID: 10921767
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.